Home Cart 0 Sign in  
X

[ CAS No. 97004-04-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 97004-04-1
Chemical Structure| 97004-04-1
Chemical Structure| 97004-04-1
Structure of 97004-04-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 97004-04-1 ]

Related Doc. of [ 97004-04-1 ]

Alternatived Products of [ 97004-04-1 ]

Product Details of [ 97004-04-1 ]

CAS No. :97004-04-1 MDL No. :MFCD00673153
Formula : C6H7ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :XPARFBOWIYMLMY-UHFFFAOYSA-N
M.W : 142.59 Pubchem ID :7020927
Synonyms :

Calculated chemistry of [ 97004-04-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 36.92
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.69 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.39
Log Po/w (XLOGP3) : 0.67
Log Po/w (WLOGP) : 1.04
Log Po/w (MLOGP) : 0.49
Log Po/w (SILICOS-IT) : 1.61
Consensus Log Po/w : 1.04

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.57
Solubility : 3.81 mg/ml ; 0.0267 mol/l
Class : Very soluble
Log S (Ali) : -1.06
Solubility : 12.3 mg/ml ; 0.0864 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.66
Solubility : 0.311 mg/ml ; 0.00218 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 97004-04-1 ]

Signal Word:Danger Class:9
Precautionary Statements:P264-P273-P280-P280-P337+P313-P391 UN#:3077
Hazard Statements:H315-H318-H410 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 97004-04-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 97004-04-1 ]
  • Downstream synthetic route of [ 97004-04-1 ]

[ 97004-04-1 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
  • 2
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 23100-12-1 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[2] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[3] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[4] Bulletin of the Chemical Society of Japan, 2000, vol. 73, # 5, p. 1227 - 1231
  • 3
  • [ 124-41-4 ]
  • [ 97004-04-1 ]
  • [ 262295-96-5 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2003, vol. 51, # 17, p. 5030 - 5035
  • 4
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 23100-12-1 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[2] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[3] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[4] Bulletin of the Chemical Society of Japan, 2000, vol. 73, # 5, p. 1227 - 1231
  • 5
  • [ 70258-18-3 ]
  • [ 97004-04-1 ]
Reference: [1] Patent: US5084459, 1992, A,
[2] Patent: CN103242225, 2016, B,
[3] Patent: , 2016, , . Location in patent: Paragraph 0004; 0007
[4] Patent: US5034404, 1991, A,
  • 6
  • [ 3731-52-0 ]
  • [ 75-44-5 ]
  • [ 97004-04-1 ]
YieldReaction ConditionsOperation in experiment
87% With sodium hydroxide; dihydrogen peroxide; trimethylamine In hydrogenchloride; chloroform; water EXAMPLE 7
Manufacturing of 3-(aminomethyl)-6-chloropyridine starting from 3-(aminomethyl)pyridine: STR18
To a suspension consisting of 3-pyridine methane amine in an amount of 21.6g (0.2 mol), 80 ml aqueous solution of sodium hydroxide in an amount of 8.8g and chloroform in a volume of 60 ml, was fed dropwise isopropoxycarbonyl chloride in an amount of 25.7 g (0.21 mol) at a temperature of from 5° to 10° C. while stirring and spending 30 minutes, and thereaction mixture was further stirred for 30 minutes.
After separating the mixture, the organic layer was concentrated under reduced pressure and wasthen dissolved in 20 ml water together with sodium tungstate in an amount of 0.58 g and 35percent hydrochloric acid in an amount of 1.0 g.
To this solution, 34.5percent hydrogen peroxide solution in an amount of 27.6 g was fed dropwise at 100° C. while spending 30 minutes.
After adjusting the pH of the solution to 5 and allowing the solution to proceed a reaction for 3.5 hours at 100° C., the solution was then cooled down to a room temperature and added with hypo to an extent that an iodo-starch reaction in the solution changes to the negative one.
The reaction mixturewas then repeatedly extracted with chloroform in a volume of 100 ml, and all of the chloroform solution collected together was subjected to an azeotropic dehydration.
To 250 ml chloroform solution obtained as described above, was added trimethylamine in an amount of 30.0 g (0.51 mol), and the resultant solution was added phosgene in an amount of 24.0 g(0.24 mol) at -5° C. while stirring and spending 1 hour.
The reaction mixture was then transferred into an autoclave, whereto hydrogen chloride gas in an amount of 67.0 g was subsequently introduced, and the solution was allowed to a reaction for 5 hours at 50° C. under a pressure of 5 kgf/cm2 while stirring.
After cooling the solution to aroom temperature, the solution was then extracted with 35percent hydrochloric acid in a volume of 160 ml.
The aqueous solution of hydrochloric acid obtained was then heated for 3.5 hours at a temperature of from 90°to 65° C.
After cooling the solution to a room temperature, the reaction mixture was then added with 28percent aqueous solution of sodium hydroxide to adjust the pH of the solution to 13.5.
The solution was then extracted with 150 ml chloroform, and the aqueous layer was further repeatedly extracted with chloroform.
All chloroform layers were collectedtogether to dry it with magnesium sulfate and the solvent therein was removed by distillation, thereby affording 3-(aminomethyl)-6-chloropyridine in an amount of 24.8 g in a crystalline form The yield was 87percent.
Reference: [1] Patent: US5744608, 1998, A,
  • 7
  • [ 1080018-12-7 ]
  • [ 97004-04-1 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With hydrogenchloride; water In methanol at 75 - 80℃; for 6 h;
Stage #2: With sodium hydroxide In methanol; chloroform; water
(Example 5) Production of (2-chlorogyridin-5-yl)methylamine (4); To 0.77 g (1.66 mol) of 1,3,5-tris[(2-chloropyridin-5-yl)methyl]-1,3,5-perhydrotriazine (II-4) were sequentially added 0.40 g of methanol and 1.83 g of concentrated hydrochloric acid, and the resulting mixture was stirred at 75 to 80°C for 6 hours. The reaction mixture was then diluted with chloroform, and following conversion of the mixture to an alkaline state by adding a 28percent aqueous solution of sodium hydroxide, the chloroform layer was separated and concentrated, yielding 0.68 g (yield: 95percent) of (2-chloropyridin-5-yl)methylamine (III-1).
95%
Stage #1: With hydrogenchloride In methanol at 75 - 80℃; for 6 h;
Stage #2: With sodium hydroxide In methanol; chloroform; water
Example 5
Production of (2-chloropyridin-5-yl)methylamine (4)
To 0.77 g (1.66 mol) of 1,3,5-tris[(2-chloropyridin-5-yl)methyl]-1,3,5-perhydrotriazine (II-4) were sequentially added 0.40 g of methanol and 1.83 g of concentrated hydrochloric acid, and the resulting mixture was stirred at 75 to 80° C. for 6 hours.
The reaction mixture was then diluted with chloroform, and following conversion of the mixture to an alkaline state by adding a 28percent aqueous solution of sodium hydroxide, the chloroform layer was separated and concentrated, yielding 0.68 g (yield: 95percent) of (2-chloropyridin-5-yl)methylamine (III-1).
Reference: [1] Patent: EP2141149, 2010, A1, . Location in patent: Page/Page column 17
[2] Patent: US2010/121054, 2010, A1, . Location in patent: Page/Page column 9
  • 8
  • [ 33252-28-7 ]
  • [ 97004-04-1 ]
Reference: [1] Patent: WO2011/161615, 2011, A1, . Location in patent: Page/Page column 58
[2] Journal of Medicinal Chemistry, 2017, vol. 60, # 19, p. 7965 - 7983
  • 9
  • [ 136918-14-4 ]
  • [ 70258-18-3 ]
  • [ 97004-04-1 ]
Reference: [1] Patent: CN104788378, 2017, B, . Location in patent: Paragraph 0057; 0058; 0060
  • 10
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
  • 11
  • [ 120739-60-8 ]
  • [ 97004-04-1 ]
YieldReaction ConditionsOperation in experiment
9.5 g With hydrazine hydrate In ethanolReflux The above-mentioned the resulting solid is soluble in ethanol (150 ml) in, mechanical stirring 15-30min rear, dropping 8-10mL hydrazine hydrate, reflux 2-6hr, filtering, using 20percent aqueous sodium hydroxide solution of adjusting PH value to be alkaline, dichloromethane extraction, water washing, drying by anhydrous sodium sulfate, decompression removes dissolved strawcoloured liquid 2-chloro-5-ammonia methylpyridinio 9.50g, content 99.0percent, GC-MS (M +) (EI, 70eV, m/z) (relativeintensity percent) calc: 142; found: 142.
Reference: [1] Journal of Agricultural and Food Chemistry, 2008, vol. 56, # 1, p. 204 - 212
[2] Patent: CN103242225, 2016, B, . Location in patent: Paragraph 0096; 0098
  • 12
  • [ 33252-28-7 ]
  • [ 3731-52-0 ]
  • [ 23100-12-1 ]
  • [ 97004-04-1 ]
Reference: [1] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[2] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[3] Tetrahedron Letters, 1999, vol. 40, # 32, p. 5885 - 5888
[4] Bulletin of the Chemical Society of Japan, 2000, vol. 73, # 5, p. 1227 - 1231
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 97004-04-1 ]

Chlorides

Chemical Structure| 6271-78-9

[ 6271-78-9 ]

6-Chloropyridine-3-carboxamide

Similarity: 0.80

Chemical Structure| 58142-49-7

[ 58142-49-7 ]

3-Chloroisoquinolin-5-amine

Similarity: 0.78

Chemical Structure| 14432-12-3

[ 14432-12-3 ]

4-Amino-2-chloropyridine

Similarity: 0.76

Chemical Structure| 51564-92-2

[ 51564-92-2 ]

6-Chloro-4-methylpyridin-2-amine

Similarity: 0.75

Chemical Structure| 33252-28-7

[ 33252-28-7 ]

6-Chloronicotinonitrile

Similarity: 0.75

Amines

Chemical Structure| 6271-78-9

[ 6271-78-9 ]

6-Chloropyridine-3-carboxamide

Similarity: 0.80

Chemical Structure| 58142-49-7

[ 58142-49-7 ]

3-Chloroisoquinolin-5-amine

Similarity: 0.78

Chemical Structure| 14432-12-3

[ 14432-12-3 ]

4-Amino-2-chloropyridine

Similarity: 0.76

Chemical Structure| 51564-92-2

[ 51564-92-2 ]

6-Chloro-4-methylpyridin-2-amine

Similarity: 0.75

Chemical Structure| 3731-52-0

[ 3731-52-0 ]

Pyridin-3-ylmethanamine

Similarity: 0.75

Related Parent Nucleus of
[ 97004-04-1 ]

Pyridines

Chemical Structure| 6271-78-9

[ 6271-78-9 ]

6-Chloropyridine-3-carboxamide

Similarity: 0.80

Chemical Structure| 14432-12-3

[ 14432-12-3 ]

4-Amino-2-chloropyridine

Similarity: 0.76

Chemical Structure| 51564-92-2

[ 51564-92-2 ]

6-Chloro-4-methylpyridin-2-amine

Similarity: 0.75

Chemical Structure| 3731-52-0

[ 3731-52-0 ]

Pyridin-3-ylmethanamine

Similarity: 0.75

Chemical Structure| 33252-28-7

[ 33252-28-7 ]

6-Chloronicotinonitrile

Similarity: 0.75